Regulation of Osteoclast Differentiation and Activity by Lipid Metabolism

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2021 Jan 12

PMID 33430327

Citations 37

Authors

Haemin Kim

Brian Oh

Kyung-Hyun Park-Min

Affiliations

Soon will be listed here.

Abstract

Bone is a dynamic tissue and is constantly being remodeled by bone cells. Metabolic reprogramming plays a critical role in the activation of these bone cells and skeletal metabolism, which fulfills the energy demand for bone remodeling. Among various metabolic pathways, the importance of lipid metabolism in bone cells has long been appreciated. More recent studies also establish the link between bone loss and lipid-altering conditions-such as atherosclerotic vascular disease, hyperlipidemia, and obesity-and uncover the detrimental effect of fat accumulation on skeletal homeostasis and increased risk of fracture. Targeting lipid metabolism with statin, a lipid-lowering drug, has been shown to improve bone density and quality in metabolic bone diseases. However, the molecular mechanisms of lipid-mediated regulation in osteoclasts are not completely understood. Thus, a better understanding of lipid metabolism in osteoclasts can be used to harness bone cell activity to treat pathological bone disorders. This review summarizes the recent developments of the contribution of lipid metabolism to the function and phenotype of osteoclasts.

Citing Articles

Modulatory role of exogenous arachidonic acid in periodontitis with type 2 diabetes mellitus mice.

Chen X, He Y, Zhou Y, Gong H, Zhang J, Qiu G BMC Oral Health. 2025; 25(1):264.

PMID: 39972454 PMC: 11841135. DOI: 10.1186/s12903-025-05525-1.

The association of lipids and novel non-statin lipid-lowering drug target with osteoporosis: evidence from genetic correlations and Mendelian randomization.

Zheng Q, Lin R, Wang D, Chen R, Xu W BMC Musculoskelet Disord. 2025; 26(1):107.

PMID: 39893413 PMC: 11787747. DOI: 10.1186/s12891-024-08160-z.

Case Report: single low-dose of denosumab as a trigger of MRONJ development in a patient with osteoporosis after bisphosphonate therapy.

Szaraz D, Perina V, Treglerova J, Machacek C, Zendulka O, Borilova Linhartova P Front Oral Health. 2024; 5:1473049.

PMID: 39697786 PMC: 11652535. DOI: 10.3389/froh.2024.1473049.

Revealing the core active pharmaceutical ingredients and targets of Jie-gu capsules for fracture treatment through network pharmacology and mendelian randomization.

Wang Y, Ding S, Gao F, Jia Y, Wang X Medicine (Baltimore). 2024; 103(49):e40798.

PMID: 39654220 PMC: 11630937. DOI: 10.1097/MD.0000000000040798.

Identification and functional analysis of genes mediating osteoclast-driven progression of osteoporosis.

Xu Q, Feng G, Zhang Z, Yan J, Tang Z, Wang R Sci Prog. 2024; 107(4):368504241300723.

PMID: 39587887 PMC: 11590132. DOI: 10.1177/00368504241300723.

References

Petit C, Batool F, Bugueno I, Schwinte P, Benkirane-Jessel N, Huck O . Contribution of Statins towards Periodontal Treatment: A Review. Mediators Inflamm. 2019; 2019:6367402. PMC: 6415285. DOI: 10.1155/2019/6367402. View

Oh S, Sul O, Kim Y, Kim H, Yu R, Suh J . Saturated fatty acids enhance osteoclast survival. J Lipid Res. 2010; 51(5):892-9. PMC: 2853456. DOI: 10.1194/jlr.M800626. View

Pinals R, Jabbs J . Type-IV hyperlipoproteinaemia and transient osteoporosis. Lancet. 1972; 2(7783):929. DOI: 10.1016/s0140-6736(72)92571-8. View

Kruger M, Coetzee M, Haag M, Weiler H . Long-chain polyunsaturated fatty acids: selected mechanisms of action on bone. Prog Lipid Res. 2010; 49(4):438-49. DOI: 10.1016/j.plipres.2010.06.002. View

Pedersen T, Tobert J . Simvastatin: a review. Expert Opin Pharmacother. 2004; 5(12):2583-96. DOI: 10.1517/14656566.5.12.2583. View

Janghorbani M, van Dam R, Willett W, Hu F . Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007; 166(5):495-505. DOI: 10.1093/aje/kwm106. View

Azuma M, Gomes-Filho J, Ervolino E, Pipa C, Cardoso C, Andrada A . Omega 3 Fatty Acids Reduce Bone Resorption While Promoting Bone Generation in Rat Apical Periodontitis. J Endod. 2017; 43(6):970-976. DOI: 10.1016/j.joen.2017.01.006. View

Chan K, Andrade S, Boles M, Buist D, Chase G, Donahue J . Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet. 2000; 355(9222):2185-8. DOI: 10.1016/S0140-6736(00)02400-4. View

Ohnaka K, Shimoda S, Nawata H, Shimokawa H, Kaibuchi K, Iwamoto Y . Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochem Biophys Res Commun. 2001; 287(2):337-42. DOI: 10.1006/bbrc.2001.5597. View

10.

Lucas S, Omata Y, Hofmann J, Bottcher M, Iljazovic A, Sarter K . Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun. 2018; 9(1):55. PMC: 5754356. DOI: 10.1038/s41467-017-02490-4. View

11.

Scranton R, Young M, Lawler E, Solomon D, Gagnon D, Gaziano J . Statin use and fracture risk: study of a US veterans population. Arch Intern Med. 2005; 165(17):2007-12. DOI: 10.1001/archinte.165.17.2007. View

12.

Nevius E, Pinho F, Dhodapkar M, Jin H, Nadrah K, Horowitz M . Oxysterols and EBI2 promote osteoclast precursor migration to bone surfaces and regulate bone mass homeostasis. J Exp Med. 2015; 212(11):1931-46. PMC: 4612084. DOI: 10.1084/jem.20150088. View

13.

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

14.

Valderrabano R, Linares M . Diabetes mellitus and bone health: epidemiology, etiology and implications for fracture risk stratification. Clin Diabetes Endocrinol. 2018; 4:9. PMC: 5918531. DOI: 10.1186/s40842-018-0060-9. View

15.

Wend K, Wend P, Drew B, Hevener A, Miranda-Carboni G, Krum S . ERα regulates lipid metabolism in bone through ATGL and perilipin. J Cell Biochem. 2013; 114(6):1306-14. PMC: 5879770. DOI: 10.1002/jcb.24470. View

16.

Kumari M, Martande S, Pradeep A . Subgingivally delivered 1.2% atorvastatin in the treatment of chronic periodontitis among smokers: a randomized, controlled clinical trial. J Investig Clin Dent. 2016; 8(2). DOI: 10.1111/jicd.12213. View

17.

Kasonga A, Kruger M, Coetzee M . Activation of PPARs Modulates Signalling Pathways and Expression of Regulatory Genes in Osteoclasts Derived from Human CD14+ Monocytes. Int J Mol Sci. 2019; 20(7). PMC: 6479901. DOI: 10.3390/ijms20071798. View

18.

Khosla S, Atkinson E, Riggs B, Melton 3rd L . Relationship between body composition and bone mass in women. J Bone Miner Res. 1996; 11(6):857-63. DOI: 10.1002/jbmr.5650110618. View

19.

Rendina-Ruedy E, Rosen C . Lipids in the Bone Marrow: An Evolving Perspective. Cell Metab. 2019; 31(2):219-231. PMC: 7004849. DOI: 10.1016/j.cmet.2019.09.015. View

20.

Mullen P, Yu R, Longo J, Archer M, Penn L . The interplay between cell signalling and the mevalonate pathway in cancer. Nat Rev Cancer. 2016; 16(11):718-731. DOI: 10.1038/nrc.2016.76. View